UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000015352
Receipt No. R000017848
Official scientific title of the study A randamized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy of oral administration of probiotic LKM512 and arginine on function of vascular endothelium in individuals with pre-metabolic syndrome
Date of disclosure of the study information 2014/10/07
Last modified on 2018/06/29 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A randamized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy of oral administration of probiotic LKM512 and arginine on function of vascular endothelium in individuals with pre-metabolic syndrome
Title of the study (Brief title) Effects of probiotic LKM512 and arginine on function of vascular endothelium
Region
Japan

Condition
Condition pre-metabolic syndrome
Classification by specialty
Medicine in general
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy of oral administration of probiotic LKM512 and arginine on function of vascular endothelium in patients with pre-metabolic syndrome
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes RH-PAT(Endo-PAT)
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 The volunteer were given an 8-week treatment with oral administration of bifidobacteria LKM512 powder (6 billion bacterial cells/stick) and 3 arginine tablets (100mg/tablet) two times per day.
Interventions/Control_2 The volunteer were given an 8-week treatment with oral administration of placebo powder without bifidobacteria LKM512 and 3 placebo tablets without arginine two times per day.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit
75 years-old >
Gender Male and Female
Key inclusion criteria Outpatients whose BMl is more than 25.0
Key exclusion criteria 1. Outpatients whose BMl is more than 25.0
2. Subjects who take a medicine for dyslipidemia treatment
3. Serious subjects who have complications with cardiac disease, hepatic disease,and/or renal disease
4. Subjects who had serious gastrointestinal disease in the past
5. Subjects who take hypotensive medicines
6. Subjects who have serious constipation
7. Subjects who was enrolled in other trails within one month
8. Inappropriate cases evaluated by doctors

Target sample size 40

Research contact person
Name of lead principal investigator Mitsuharu Matsumoto
Organization Kyodo Milk Industry Co. Ltd.
Division name Research Laboratories
Address 20-1 Hirai, Hinode-machi, Nishitama-gun, Tokyo 190-0182
TEL 042-597-5911
Email m-matumoto@meito.co.jp

Public contact
Name of contact person Satoshi Sakurai
Organization imeQ CO. Ltd.
Division name CRO division
Address a vous primus Bld, 2-14-6, nishiwaseda, Shinjuku-ku, Tokyo 169-0075
TEL 03-6279-3591
Homepage URL
Email s-sakurai@imeq.co.jp

Sponsor
Institute Kyodo Milk Industry Co. Ltd.
Institute
Department

Funding Source
Organization Kyodo Milk Industry Co. Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 医療法人社団 札幌百合の会病院 (北海道)

Other administrative information
Date of disclosure of the study information
2014 Year 10 Month 07 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 09 Month 11 Day
Anticipated trial start date
2014 Year 10 Month 07 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 10 Month 06 Day
Last modified on
2018 Year 06 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017848